PULSE BIOSCIENCES (PLSE) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
PULSE BIOSCIENCES insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $26.8M and 1 sold $2.9M of PLSE stock on the open market.
Get emailed when insiders cluster-buy stocks like PLSE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PLSE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $200K | 4 | — | 0 |
| Q2 2026 | $26.6M | 4 | — | 0 |
| Q1 2026 | — | 0 | $2.9M | 7 |
| Q4 2025 | — | 0 | $85K | 1 |
Valuation, profit and volume
Pick score 34/100Summary
Over the past 12 months, 3 PULSE BIOSCIENCES, INC. insiders reported open-market purchases totaling $26.8M, while 1 insider reported sales totaling $2.9M. Among insiders with enough purchase history to measure, Paul A Laviolette (CEO) has the highest Insider Score at 100. 8 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
PLSE stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 2SEC | Liane Rae TeplitskyCOO | Buy | 1,0014,095 held (+32%) | $49.95 | $50K | +7.7% | — |
| Sep 2SEC | Liane Rae TeplitskyCOO | Buy | 1,0243,094 held (+49%) | $48.80 | $50K | +10.3% | — |
| Aug 28SEC | Liane Rae TeplitskyCOO | Buy | 1,0342,070 held (+100%) | $48.35 | $50K | +11.3% | — |
| Aug 28SEC | Liane Rae TeplitskyCOO | Buy | 1,036new position | $48.24 | $50K | +11.5% | — |
| May 15SEC | Robert W DugganDirector | Buy | 660,23348,370,047 held (+1%) | $19.69 | $13.0M | +173.3% | 98 |
| May 11SEC | Robert W DugganDirector | Buy | 660,23348,211,433 held (+1%) | $19.69 | $13.0M | +173.3% | 98 |
| May 11SEC | Paul A LavioletteCEO | Buy | 15,00015,846 held (+1773%) | $19.69 | $295K | +173.3% | 100 |
| May 11SEC | Paul A LavioletteCEO | Buy | 15,000new position | $19.69 | $295K | +173.3% | 100 |
| Feb 23SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 5,00043,298 held (−10%) | $23.64 | $118K | +127.6% | — |
| Feb 17SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $23.63 | $473K | +127.7% | — |
| Feb 17SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $23.53 | $471K | +128.7% | — |
| Feb 17SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $23.37 | $467K | +130.3% | — |
| Feb 11SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $25.20 | $504K | +113.5% | — |
| Feb 11SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $23.52 | $470K | +128.8% | — |
| Feb 11SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 20,00043,298 held (−32%) | $21.45 | $429K | +150.9% | — |
| Oct 7SEC | Kevin Patrick DanahyChief Commercial Officer | Sell Plan | 4,60043,298 held (−10%) | $18.53 | $85K | +190.4% | — |
Insiders at PULSE BIOSCIENCES, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Robert W DugganDirector | $26.0M | — | May 15, 2026 | 98 |
| Kevin Patrick DanahyChief Commercial Officer | — | $3.0M | Feb 23, 2026 | — |
| Paul A LavioletteCEO | $591K | — | May 11, 2026 | 100 |
| Liane Rae TeplitskyCOO | $200K | — | Sep 2, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
PLSE stock: common questions
Are PULSE BIOSCIENCES, INC. insiders buying PLSE stock?
In the past 12 months, 3 insiders reported open-market purchases of PLSE worth $26.8M. The latest was COO Liane Rae Teplitsky bought $50K of PLSE at $49.95 — raises the stake by 32%.
Are PULSE BIOSCIENCES, INC. insiders selling PLSE stock?
1 insiders reported sales worth $2.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PLSE's 52-week range?
Over the past year PLSE has traded between $12.66 and $55.20. It last closed at $53.81 on Oct 9, 2026.